Agenda of the event

TimeTopicSpeaker
5 mins Introduction Priya Jain
Global Medical Director, Respiratory Franchise, GSK
10 mins Management of mild asthma Dave Leather
Medical Vice President, Respiratory Franchise, GSK
10 mins Importance of adherence in managing mild to moderate asthma Monica Fletcher
Global Medical Expert, GSK
30 mins Panel Discussions and Q n A All
5 mins Closing comments All

Presenters

Dr. Priya Jain

She joined GSK in 2008 as the respiratory lead for Singapore Malaysia and has held a variety of positions within the company including paediatric vaccine area head. Priya recently has taken the head of classical respiratory portfolio and leads a team of medical directors and scientific director who work for GSK providing scientific expertise for disease and products

David Leather

Dave Leather is a Medical Vice President in the Respiratory Franchise at GSK, based at GSK House in London in the UK. He leads the Global Medical Expert team: a team of world renowned Respiratory experts who work for GSK providing internal scientific and clinical expertise to support promoted medicines and those in development. Previously he led a team responsible for developing phase lll and phase lV trials for respiratory medicines. He also has a leadership role in “real world pragmatic trials” and is the Franchise leader of the internationally recognised Salford Lung Study. He joined GSK in 2000 and has held a variety of posts within the company. Originally a primary care physician in Bolton with an interest in respiratory disease, Dave managed asthma and COPD clinics in a primary care setting and held a post as a clinical assistant in Respiratory Medicine at University Hospital Aintree in Liverpool.

Monica Fletcher

Monica Fletcher joined GSK in 2017 following an extensive career in primary care respiratory nursing, education and research. As Chief Executive of Education for Health, a global education charity she championed the role of primary care in the delivery of respiratory care across the world.

AWA/NA/0003/19b | Date of preparation: March 2019